Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: a cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population

Table 2 Medication use among REGARDS participants hospitalized for HFrEF

	Admission medication list^a	Discharge medication list^a	Claims within 1 year^b
Beta-blocker
Discharged home	74%	81%	66%
Discharged to long-term care	82%	95%	68%
HFrEF beta-blocker^c
Discharged home	52%	60%	49%
Discharged to long-term care	50%	68%	50%
ACEI/ARB
Discharged home	41%	54%	47%
Discharged to long-term care	41%	55%	45%
Diuretic
Discharged home	71%	87%	72%
Discharged to long-term care	77%	86%	50%
Loop diuretic
Discharged home	66%	85%	70%
Discharged to long-term care	77%	86%	50%
Hydralazine in combination with isosorbide dinitrate
Discharged home	14%	23%	23%
Discharged to long-term care	9%	5%	5%
Aldosterone receptor antagonist
Discharged home	14%	22%	23%
Discharged to long-term care	9%	14%	5%

HFrEF Heart failure with reduced ejection fraction, ACEI/ARB Angiotensin converting enzyme inhibitor or angiotensin receptor blocker
^aDetermined from review of medical records
^bDetermined using Medicare pharmacy claims data
^cCarvedilol, metoprolol succinate, or bisoprolol

ISSN: 1471-2261